Hepatitis B reactivation after oral capecitabine treatment in a rectum cancer patient with isolated anti-HBc IgG positivity.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners(2022)

Cited 0|Views7
No score
Abstract
To the best of our knowledge, this is the first case report describing HBV reactivation after chemotherapy with capecitabine for rectal cancer in a patient with isolated anti-HBc IgG positivity. Our case shows that HBV reactivation may develop in a low-risk patient with a low degree of immunosuppression.
More
Translated text
Key words
HBV reactivation,capecitabine,immunosuppressive therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined